This is a table of type noun and their frequencies. Use it to search & browse the list to learn more about your study carrel.
noun | frequency |
---|---|
patients | 23081 |
cell | 7890 |
cells | 6489 |
disease | 5241 |
treatment | 4649 |
transplantation | 4483 |
years | 3810 |
patient | 3793 |
transplant | 3588 |
stem | 3572 |
results | 3290 |
risk | 3213 |
donor | 3204 |
days | 3204 |
months | 3169 |
therapy | 3139 |
study | 2987 |
age | 2978 |
group | 2774 |
day | 2620 |
blood | 2606 |
time | 2475 |
infection | 2448 |
survival | 2444 |
infections | 2394 |
pts | 2270 |
conditioning | 2224 |
analysis | 2108 |
diagnosis | 2097 |
graft | 1970 |
cases | 1902 |
relapse | 1875 |
data | 1829 |
dose | 1800 |
response | 1744 |
incidence | 1734 |
recipients | 1723 |
methods | 1666 |
children | 1662 |
marrow | 1645 |
mortality | 1615 |
range | 1528 |
bone | 1504 |
levels | 1452 |
regimen | 1442 |
donors | 1435 |
prophylaxis | 1418 |
grade | 1305 |
case | 1298 |
use | 1243 |
number | 1232 |
follow | 1221 |
chemotherapy | 1218 |
conclusions | 1214 |
leukemia | 1212 |
year | 1207 |
syndrome | 1180 |
allo | 1177 |
rate | 1169 |
studies | 1167 |
failure | 1163 |
complications | 1156 |
allogeneic | 1140 |
outcome | 1120 |
groups | 1111 |
factors | 1111 |
disclosure | 1046 |
engraftment | 1030 |
deficiency | 1019 |
outcomes | 992 |
virus | 989 |
background | 971 |
cohort | 967 |
host | 941 |
median | 939 |
function | 922 |
symptoms | 911 |
gene | 904 |
lymphoma | 886 |
expression | 873 |
lung | 871 |
post | 864 |
none | 847 |
mutations | 837 |
remission | 834 |
period | 827 |
mutation | 811 |
population | 792 |
term | 775 |
development | 765 |
effect | 761 |
pneumonia | 747 |
kg | 747 |
conclusion | 747 |
status | 745 |
immunodeficiency | 735 |
level | 734 |
chimerism | 727 |
type | 726 |
toxicity | 725 |
control | 718 |
liver | 716 |
role | 715 |
diseases | 712 |
care | 705 |
skin | 689 |
factor | 688 |
rates | 687 |
recovery | 682 |
cancer | 681 |
count | 679 |
platelet | 673 |
weeks | 672 |
malignancies | 660 |
effects | 659 |
adult | 657 |
progression | 656 |
history | 653 |
reactivation | 648 |
impact | 643 |
regimens | 636 |
interest | 632 |
lymphocyte | 631 |
method | 617 |
ml | 612 |
samples | 610 |
death | 602 |
life | 596 |
infusion | 593 |
evaluation | 586 |
addition | 584 |
objectives | 582 |
activity | 581 |
intensity | 580 |
criteria | 577 |
efficacy | 568 |
fever | 563 |
serum | 561 |
tumor | 555 |
findings | 549 |
presence | 547 |
difference | 546 |
phase | 544 |
onset | 544 |
recipient | 542 |
conflict | 539 |
management | 537 |
source | 530 |
center | 529 |
differences | 527 |
system | 526 |
sibling | 522 |
cord | 516 |
protein | 515 |
antibody | 513 |
neutropenia | 512 |
transplants | 511 |
test | 510 |
induction | 509 |
family | 509 |
hct | 507 |
× | 498 |
combination | 494 |
pain | 489 |
total | 484 |
improvement | 482 |
line | 481 |
experience | 478 |
disorders | 478 |
introduction | 476 |
neutrophil | 474 |
characteristics | 472 |
cause | 471 |
evidence | 469 |
gvhd | 467 |
trial | 466 |
lymphocytes | 465 |
episodes | 461 |
flow | 461 |
increase | 460 |
course | 457 |
influenza | 455 |
events | 454 |
testing | 453 |
anemia | 453 |
doses | 452 |
administration | 449 |
safety | 443 |
sequencing | 442 |
score | 435 |
reconstitution | 435 |
complication | 434 |
responses | 431 |
weight | 430 |
mobilization | 429 |
loss | 424 |
protocol | 423 |
approach | 417 |
setting | 415 |
agvhd | 415 |
biopsy | 412 |
presentation | 411 |
procedure | 402 |
hospital | 402 |
myeloma | 400 |
phenotype | 399 |
features | 396 |
adults | 391 |
organ | 391 |
duration | 391 |
frequency | 390 |
drug | 390 |
laboratory | 389 |
reduction | 388 |
genes | 387 |
majority | 386 |
series | 385 |
tract | 384 |
immunoglobulin | 377 |
ratio | 376 |
morbidity | 376 |
stage | 375 |
transfusion | 371 |
model | 370 |
malignancy | 370 |
proliferation | 368 |
cytometry | 367 |
controls | 367 |
option | 365 |
auto | 365 |
review | 364 |
activation | 364 |
agents | 362 |
antigen | 361 |
body | 359 |
quality | 358 |
receptor | 358 |
plasma | 357 |
memory | 355 |
antibodies | 355 |
mice | 352 |
grafts | 352 |
vaccine | 351 |
viruses | 350 |
culture | 345 |
cyclophosphamide | 343 |
collection | 341 |
therapies | 340 |
design | 340 |
centers | 340 |
dna | 339 |
nothing | 339 |
changes | 338 |
tissue | 335 |
depletion | 335 |
month | 334 |
association | 334 |
order | 333 |
involvement | 332 |
prognosis | 330 |
variant | 328 |
lesions | 328 |
detection | 328 |
screening | 324 |
strategy | 321 |
steroid | 319 |
table | 319 |
os | 316 |
health | 314 |
myeloid | 313 |
cgvhd | 313 |
busulfan | 311 |
value | 310 |
absence | 309 |
immunosuppression | 308 |
counts | 308 |
steroids | 307 |
male | 306 |
aim | 305 |
assay | 303 |
subjects | 303 |
severity | 300 |
signs | 299 |
numbers | 299 |
cr | 299 |
variants | 296 |
values | 296 |
disorder | 296 |
process | 295 |
monitoring | 293 |
reports | 292 |
report | 292 |
tumors | 290 |
lines | 290 |
sepsis | 289 |
parents | 287 |
vaccination | 284 |
strategies | 283 |
assessment | 283 |
need | 282 |
survivors | 280 |
inflammation | 278 |
dysfunction | 278 |
research | 277 |
dl | 276 |
abnormalities | 276 |
immunity | 274 |
information | 273 |
manifestations | 270 |
conditions | 269 |
thrombocytopenia | 269 |
target | 269 |
rejection | 267 |
production | 267 |
guidelines | 267 |
trials | 264 |
admission | 264 |
mg | 262 |
part | 260 |
ci | 259 |
tests | 258 |
literature | 258 |
end | 258 |
individuals | 256 |
comparison | 255 |
procedures | 254 |
institution | 254 |
igg | 254 |
fludarabine | 254 |
event | 254 |
vivo | 253 |
subsets | 250 |
infants | 249 |
date | 249 |
prevention | 248 |
lack | 248 |
causes | 248 |
parameters | 247 |
expansion | 246 |
side | 245 |
analyses | 245 |
resolution | 244 |
adenovirus | 243 |
product | 242 |
correlation | 242 |
week | 240 |
selection | 240 |
platelets | 240 |
growth | 240 |
cytokine | 239 |
cycles | 239 |
inhibitor | 238 |
antibiotics | 237 |
replacement | 237 |
support | 236 |
drugs | 235 |
infusions | 234 |
prevalence | 234 |
irradiation | 233 |
defects | 232 |
cultures | 232 |
salvage | 231 |
pathway | 230 |
sample | 229 |
models | 229 |
index | 228 |
females | 228 |
significance | 228 |
times | 228 |
unit | 227 |
child | 227 |
volume | 227 |
decrease | 226 |
transfusions | 225 |
products | 225 |
males | 224 |
stimulation | 222 |
percentage | 222 |
injury | 220 |
mud | 219 |
markers | 216 |
apheresis | 216 |
generation | 214 |
treatments | 214 |
inhibitors | 213 |
female | 213 |
condition | 213 |
chest | 213 |
regression | 212 |
haplo | 211 |
proportion | 210 |
car | 209 |
variables | 208 |
sex | 208 |
kidney | 208 |
cyclosporine | 208 |
probability | 205 |
program | 205 |
terms | 205 |
maintenance | 204 |
hours | 204 |
diarrhea | 204 |
result | 203 |
potential | 203 |
corticosteroids | 202 |
practice | 198 |
populations | 198 |
hospitalization | 198 |
interval | 197 |
gender | 197 |
acid | 197 |
agent | 196 |
survey | 195 |
assays | 195 |
mscs | 195 |
co | 194 |
childhood | 194 |
radiation | 193 |
thalassemia | 192 |
site | 192 |
intervention | 192 |
initiation | 192 |
work | 190 |
others | 189 |
occurrence | 189 |
examination | 189 |
exposure | 188 |
neutrophils | 188 |
hr | 188 |
bacteremia | 187 |
concentration | 186 |
deaths | 185 |
hemoglobin | 184 |
authors | 184 |
panel | 183 |
damage | 182 |
spectrum | 181 |
profile | 180 |
cost | 180 |
brain | 180 |
consolidation | 179 |
load | 179 |
identification | 178 |
scores | 178 |
imaging | 176 |
cytokines | 176 |
knowledge | 175 |
contrast | 173 |
benefit | 172 |
autoimmunity | 172 |
form | 171 |
centre | 169 |
arm | 169 |
point | 168 |
capacity | 167 |
oncology | 166 |
pathogens | 166 |
records | 165 |
options | 165 |
cycle | 165 |
blasts | 165 |
resistance | 164 |
globulin | 163 |
fibrosis | 163 |
differentiation | 163 |
diagnoses | 162 |
defect | 162 |
cohorts | 162 |
toxicities | 160 |
copies | 159 |
susceptibility | 159 |
rhinovirus | 158 |
episode | 158 |
recurrence | 158 |
pt | 158 |
objective | 156 |
reaction | 156 |
units | 155 |
organs | 155 |
deletion | 155 |
cystitis | 155 |
rituximab | 154 |
mechanism | 154 |
immunotherapy | 154 |
participants | 153 |
importance | 153 |
points | 152 |
leukaemia | 152 |
yrs | 152 |
tool | 151 |
families | 151 |
antigens | 151 |
types | 150 |
protocols | 150 |
heart | 150 |
bleeding | 150 |
trend | 149 |
sickle | 149 |
lymph | 149 |
iron | 149 |
dysregulation | 149 |
bacteria | 148 |
chain | 148 |
performance | 148 |
siblings | 147 |
ribavirin | 147 |
registry | 147 |
mass | 147 |
clinic | 147 |
biopsies | 147 |
titers | 147 |
pattern | 146 |
countries | 146 |
ability | 146 |
database | 145 |
application | 145 |
class | 145 |
hypertension | 145 |
mechanisms | 145 |
size | 145 |
syndromes | 144 |
hemorrhage | 144 |
self | 142 |
responders | 142 |
beta | 142 |
baseline | 142 |
state | 141 |
investigation | 141 |
exome | 141 |
change | 140 |
distribution | 140 |
gain | 140 |
observation | 140 |
viremia | 139 |
inhibition | 139 |
sensitivity | 139 |
marker | 139 |
viability | 138 |
hepatitis | 137 |
deficiencies | 137 |
length | 136 |
relationship | 135 |
placebo | 135 |
chart | 135 |
start | 134 |
apoptosis | 133 |
approaches | 133 |
aspergillosis | 133 |
delay | 133 |
surface | 133 |
decision | 133 |
ul | 132 |
risks | 132 |
region | 132 |
percent | 132 |
hypogammaglobulinemia | 132 |
n=2 | 131 |
alpha | 131 |
degree | 130 |
adherence | 130 |
basis | 130 |
indication | 130 |
mismatch | 130 |
sites | 130 |
ferritin | 129 |
allograft | 129 |
plerixafor | 128 |
pathogen | 128 |
materials | 128 |
neuroblastoma | 127 |
measures | 127 |
concentrations | 127 |
standard | 126 |
repertoire | 125 |
gut | 125 |
csf | 124 |
birth | 124 |
mother | 124 |
indications | 124 |
lymphomas | 123 |
allele | 123 |
urine | 122 |
team | 122 |
surveillance | 122 |
proteins | 122 |
genotype | 122 |
chromosome | 121 |
medications | 121 |
reactions | 121 |
surgery | 121 |
effector | 120 |
n=3 | 120 |
° | 119 |
immunodeficiencies | 119 |
illness | 119 |
gamma | 119 |
burden | 119 |
recommendations | 119 |
posttransplant | 118 |
corticosteroid | 118 |
isolation | 117 |
centres | 117 |
pathogenesis | 117 |
vaccines | 117 |
infant | 116 |
courses | 116 |
origin | 115 |
inclusion | 115 |
area | 115 |
tissues | 114 |
species | 114 |
medication | 114 |
forms | 114 |
education | 114 |
aspergillus | 114 |
problems | 113 |
symptom | 113 |
staff | 112 |
splenomegaly | 112 |
ptcy | 112 |
interventions | 112 |
consent | 112 |
a. | 112 |
tolerance | 112 |
gram | 111 |
community | 111 |
providers | 110 |
p. | 110 |
girl | 110 |
cm | 109 |
choice | 109 |
material | 109 |
cytotoxicity | 109 |
scan | 109 |
transfer | 108 |
reference | 108 |
radiotherapy | 108 |
outpatient | 108 |
nausea | 108 |
formation | 108 |
etiology | 108 |
discharge | 108 |
bowel | 107 |
home | 107 |
discussion | 107 |
oxygen | 107 |
progenitor | 107 |
physicians | 107 |
vs. | 106 |
ventilation | 106 |
training | 106 |
suppression | 105 |
release | 105 |
receptors | 105 |
phenotypes | 105 |
monocytes | 105 |
impairment | 105 |
feasibility | 105 |
adolescents | 105 |
cytogenetics | 104 |
interferon | 104 |
half | 104 |
timing | 103 |
pregnancy | 103 |
pneumonitis | 103 |
influence | 103 |
dosing | 103 |
context | 103 |
concern | 103 |
consensus | 102 |
complement | 102 |
i | 101 |
cough | 101 |
effectiveness | 101 |
endpoint | 101 |
mucositis | 101 |
purpose | 101 |
understanding | 101 |
sources | 101 |
⩾ | 100 |
leukocyte | 100 |
discontinuation | 100 |
colitis | 100 |
members | 99 |
kinase | 99 |
boy | 99 |
ng | 98 |
availability | 98 |
clearance | 98 |
comorbidities | 98 |
lesion | 98 |
manifestation | 98 |
subset | 98 |
rash | 98 |
tacrolimus | 98 |
transcription | 98 |
transplantations | 98 |
women | 98 |
scale | 97 |
reasons | 97 |
hmpv | 97 |
fusion | 97 |
cytopenias | 97 |
classification | 96 |
distress | 96 |
search | 96 |
yield | 96 |
mouse | 95 |
communication | 95 |
hematology | 95 |
variety | 94 |
pathology | 94 |
cryopreservation | 94 |
novel | 93 |
media | 93 |
killer | 93 |
efficiency | 93 |
immune | 92 |
goal | 92 |
sarcoma | 92 |
success | 92 |
hand | 92 |
sequence | 91 |
project | 91 |
interactions | 91 |
immunoglobulins | 91 |
granulocyte | 91 |
domain | 91 |
costs | 91 |
colony | 91 |
fluid | 91 |
mg/ | 90 |
efs | 90 |
amount | 90 |
access | 90 |
fact | 89 |
obstruction | 89 |
subgroups | 89 |
limitations | 88 |
finding | 88 |
donation | 88 |
dock8 | 88 |
positivity | 88 |
enzyme | 87 |
vector | 87 |
relapses | 87 |
csa | 87 |
creatinine | 87 |
areas | 87 |
ages | 87 |
candidiasis | 86 |
patterns | 86 |
incidences | 86 |
diversity | 86 |
summary | 86 |
karyotype | 86 |
modality | 86 |
subgroup | 86 |
peak | 85 |
lfs | 85 |
infiltration | 85 |
ad | 85 |
bronchiolitis | 84 |
catheter | 84 |
maturation | 84 |
biomarkers | 84 |
alveolar | 84 |
fi | 84 |
pneumoniae | 84 |
mononuclear | 84 |
pids | 84 |
techniques | 84 |
predictors | 84 |
shock | 84 |
necrosis | 84 |
completion | 83 |
asthma | 83 |
cancers | 83 |
overload | 83 |
content | 83 |
pairs | 83 |
recognition | 83 |
device | 82 |
admissions | 82 |
adv | 82 |
bronchiectasis | 82 |
systems | 82 |
exon | 82 |
node | 82 |
pathways | 82 |
physician | 82 |
dermatitis | 81 |
era | 81 |
rank | 81 |
properties | 81 |
hazard | 81 |
reason | 81 |
stay | 81 |
vitamin | 81 |
regulation | 81 |
spleen | 80 |
nodes | 80 |
match | 80 |
depression | 80 |
clinicians | 80 |
autoantibodies | 80 |
pid | 79 |
arthritis | 79 |
decline | 79 |
phosphorylation | 79 |
regions | 79 |
respect | 79 |
screen | 79 |
suspicion | 79 |
scans | 78 |
pbmcs | 78 |
image | 78 |
fatigue | 78 |
alternative | 78 |
+100 | 78 |
alterations | 77 |
diabetes | 77 |
nature | 77 |
fraction | 77 |
grades | 77 |
hemolysis | 77 |
subtypes | 77 |
organisms | 77 |
pressure | 77 |
problem | 77 |
targets | 77 |
validation | 77 |
periods | 77 |
technique | 76 |
questionnaire | 76 |
persistence | 76 |
measurements | 76 |
cure | 76 |
contact | 76 |
composition | 76 |
epidemiology | 75 |
blast | 75 |
consideration | 75 |
threshold | 75 |
osteosarcoma | 75 |
sct | 75 |
technology | 75 |
transduction | 74 |
lymphadenopathy | 74 |
log | 74 |
ligand | 74 |
confidence | 74 |
father | 73 |
defibrotide | 73 |
specificity | 73 |
platform | 73 |
settings | 73 |
μl | 72 |
repair | 72 |
possibility | 72 |
injection | 72 |
implementation | 72 |
hospitalizations | 72 |
fevers | 72 |
delivery | 72 |
clones | 72 |
eczema | 71 |
abscesses | 71 |
cidofovir | 71 |
reactivations | 71 |
functions | 71 |
polymerase | 71 |
alloreactivity | 70 |
barriers | 70 |
min | 70 |
cd45ra | 70 |
challenges | 70 |
lungs | 70 |
categories | 70 |
otitis | 70 |
predictor | 70 |
schedule | 70 |
utilization | 70 |
variability | 70 |
workup | 70 |
pilot | 70 |
mm3 | 69 |
curve | 69 |
dexamethasone | 69 |
missense | 69 |
challenge | 69 |
one | 69 |
practices | 69 |
protection | 69 |
β | 69 |
albumin | 68 |
algorithm | 68 |
improvements | 68 |
interaction | 68 |
matching | 68 |
muscle | 68 |
software | 68 |
specimens | 68 |
staining | 68 |
step | 68 |
advantage | 67 |
exam | 67 |
flu | 67 |
healthcare | 67 |
measurement | 67 |
sister | 67 |
stool | 67 |
vomiting | 67 |
stages | 67 |
endpoints | 66 |
beam | 66 |
benefits | 66 |
carcinoma | 66 |
component | 66 |
8) | 66 |
lymphoproliferation | 66 |
subpopulations | 66 |
tolerability | 66 |
varicella | 66 |
membrane | 66 |
institutions | 65 |
abscess | 65 |
components | 65 |
edema | 65 |
immunization | 65 |
lavage | 65 |
molecules | 65 |
peptide | 65 |
resection | 65 |
rest | 65 |
migration | 64 |
allergy | 64 |
amphotericin | 64 |
functioning | 64 |
mm | 64 |
mismatches | 64 |
modalities | 64 |
nasal | 64 |
mean | 63 |
frequencies | 63 |
harvest | 63 |
hscs | 63 |
issues | 63 |
label | 63 |
breast | 63 |
presentations | 63 |
profiles | 63 |
sirolimus | 63 |
tetanus | 63 |
transition | 63 |
tuberculosis | 63 |
appearance | 62 |
attention | 62 |
copy | 62 |
kinetics | 62 |
pet | 62 |
quantification | 62 |
questions | 62 |
sessions | 62 |
splenectomy | 62 |
intervals | 61 |
bilirubin | 61 |
bloodstream | 61 |
ctls | 61 |
decades | 61 |
mcl | 61 |
parent | 61 |
repeat | 61 |
school | 61 |
stress | 61 |
thrombosis | 61 |
needs | 61 |
assessments | 60 |
mmf | 60 |
field | 60 |
food | 60 |
medium | 60 |
fluconazole | 60 |
neck | 60 |
photopheresis | 60 |
pr | 60 |
vrti | 60 |
world | 60 |
ulcers | 59 |
spp | 59 |
rabbit | 59 |
processes | 59 |
men | 59 |
humans | 59 |
fertility | 59 |
country | 59 |
characterization | 58 |
coronavirus | 58 |
complex | 58 |
domains | 58 |
caregivers | 58 |
ascites | 58 |
department | 58 |
strains | 58 |
fungal | 58 |
kit | 58 |
meningitis | 58 |
minutes | 58 |
mouth | 58 |
nf | 58 |
journal | 58 |
nodules | 57 |
advances | 57 |
arms | 57 |
evolution | 57 |
investigations | 57 |
hypothesis | 57 |
reactivity | 57 |
relation | 57 |
tomography | 57 |
trough | 57 |
ultrasound | 57 |
incompatibility | 56 |
bal | 56 |
candidate | 56 |
concerns | 56 |
crisis | 56 |
dosage | 56 |
experiments | 56 |
hd | 56 |
hscts | 56 |
immunology | 56 |
regard | 56 |
insufficiency | 56 |
nutrition | 56 |
ones | 56 |
rescue | 56 |
serology | 56 |
signaling | 56 |
stroke | 56 |
usage | 56 |
way | 56 |
leukapheresis | 56 |
cytomegalovirus | 55 |
example | 55 |
eosinophilia | 55 |
definition | 55 |
guideline | 55 |
comorbidity | 55 |
colon | 55 |
coagulation | 55 |
alleles | 55 |
fellows | 55 |
enrollment | 55 |
gvl | 55 |
progress | 55 |
temperature | 55 |
substitution | 55 |
stat1 | 55 |
ligands | 55 |
progenitors | 55 |
mucosa | 55 |
withdrawal | 55 |
mobilisation | 55 |
leukocytes | 54 |
average | 54 |
biomarker | 54 |
boys | 54 |
carrier | 54 |
counseling | 54 |
decade | 54 |
fungi | 54 |
histology | 54 |
implications | 54 |
metastasis | 54 |
macrophages | 54 |
metabolism | 54 |
microbiota | 54 |
qol | 54 |
room | 54 |
sinusitis | 54 |
thymus | 54 |
title | 54 |
tumour | 54 |
typing | 54 |
measles | 53 |
awareness | 53 |
compartment | 53 |
eculizumab | 53 |
granulocytes | 53 |
lab | 53 |
secretion | 53 |
obliterans | 53 |
replication | 53 |
storage | 53 |
solution | 53 |
ray | 53 |
headache | 52 |
cd3 | 52 |
chemo | 52 |
cord_uid | 52 |
density | 52 |
enzymes | 52 |
environment | 52 |
helper | 52 |
osteomyelitis | 52 |
pg | 52 |
placement | 52 |
requirement | 52 |
tyrosine | 52 |
vasculitis | 52 |
anaemia | 51 |
binding | 51 |
bladder | 51 |
metastases | 51 |
consequence | 51 |
cov | 51 |
extent | 51 |
infancy | 51 |
lineage | 51 |
set | 51 |
mo | 51 |
throat | 51 |
trecs | 51 |
titer | 51 |
party | 51 |
sclerosis | 51 |
rag | 51 |
question | 51 |
/l | 50 |
genome | 50 |
aureus | 50 |
barrier | 50 |
brother | 50 |
cavity | 50 |
colonization | 50 |
elevation | 50 |
entity | 50 |
excision | 50 |
activities | 50 |
heterogeneity | 50 |
normalization | 50 |
note | 50 |
percentile | 50 |
prediction | 50 |
preparation | 50 |
resources | 50 |
subtype | 50 |
vein | 50 |
n=8 | 50 |
grading | 49 |
adhesion | 49 |
airway | 49 |
beginning | 49 |
future | 49 |
deletions | 49 |
hematuria | 49 |
pneumonias | 49 |
programs | 49 |
variation | 49 |
herpes | 49 |
errors | 48 |
associations | 48 |
collections | 48 |
demographics | 48 |
documentation | 48 |
molecule | 48 |
nk | 48 |
persons | 48 |
rr | 48 |
rv | 48 |
n=9 | 47 |
air | 47 |
aspects | 47 |
category | 47 |
hematopoiesis | 47 |
processing | 47 |
sd | 47 |
transformation | 47 |
vod | 47 |
loci | 46 |
accumulation | 46 |
action | 46 |
amino | 46 |
amplification | 46 |
calcium | 46 |
carriers | 46 |
collaboration | 46 |
fibroblasts | 46 |
location | 46 |
heparin | 46 |
locus | 46 |
provider | 46 |
γ | 46 |
means | 46 |
tandem | 46 |
swabs | 46 |
utility | 46 |
phenotyping | 46 |
observations | 46 |
neoplasms | 46 |
mitogen | 46 |
lymphohistiocytosis | 45 |
cisplatin | 45 |
description | 45 |
difficulties | 45 |
encephalopathy | 45 |
fibrinogen | 45 |
focus | 45 |
genotypes | 45 |
ls | 45 |
tools | 45 |
lysis | 45 |
serotypes | 45 |
manufacturing | 45 |
statistics | 45 |
signal | 45 |
update | 45 |
seizures | 45 |
referral | 45 |
oxidase | 45 |
mothers | 44 |
anxiety | 44 |
basal | 44 |
emergency | 44 |
enrichment | 44 |
eosinophils | 44 |
hypotension | 44 |
limit | 44 |
moment | 44 |
n=7 | 44 |
picture | 44 |
sinus | 44 |
neoplasm | 44 |
version | 44 |
situation | 44 |
visit | 44 |
sequelae | 44 |
purity | 44 |
weekly | 44 |
panels | 44 |
increases | 43 |
animal | 43 |
approval | 43 |
candidates | 43 |
cd40l | 43 |
experiences | 43 |
fish | 43 |
ganciclovir | 43 |
illnesses | 43 |
entry | 43 |
instability | 43 |
toxoplasmosis | 43 |
lad | 43 |
transmission | 43 |
translocation | 43 |
voriconazole | 43 |
record | 43 |
place | 43 |
non | 43 |
interviews | 42 |
/kg | 42 |
attempt | 42 |
dysplasia | 42 |
eligibility | 42 |
girls | 42 |
head | 42 |
hosts | 42 |
pcr | 42 |
issue | 42 |
lupus | 42 |
precursor | 42 |
prednisone | 42 |
sign | 42 |
signature | 42 |
telomere | 42 |
confirmation | 41 |
dlis | 41 |
cxcr4 | 41 |
efforts | 41 |
artery | 41 |
balance | 41 |
alemtuzumab | 41 |
account | 41 |
foxp3 | 41 |
fluorescence | 41 |
deterioration | 41 |
infl | 41 |
microorganisms | 41 |
zoster | 41 |
rearrangement | 41 |
respondents | 41 |
sequences | 41 |
thickening | 41 |
volumes | 41 |
xiap | 41 |
killing | 41 |
enhancement | 40 |
granulomas | 40 |
graftversus | 40 |
face | 40 |
exclusion | 40 |
evaluations | 40 |
abnormality | 40 |
cytarabine | 40 |
conflicts | 40 |
compound | 40 |
aggregation | 40 |
hyperplasia | 40 |
-1 | 40 |
hemophilia | 40 |
injections | 40 |
stratification | 40 |
pad | 40 |
water | 40 |
visits | 40 |
tube | 40 |
lobe | 40 |
signifi | 40 |
remissions | 40 |
pathophysiology | 40 |
opportunity | 40 |
negativity | 40 |
modification | 40 |
microscopy | 40 |
man | 40 |
malformations | 40 |
consequences | 39 |
exercise | 39 |
exception | 39 |
disability | 39 |
funding | 39 |
complexity | 39 |
combinations | 39 |
coagulopathy | 39 |
allografts | 39 |
eyes | 39 |
base | 39 |
height | 39 |
ratios | 39 |
wall | 39 |
thyroid | 39 |
switch | 39 |
limits | 39 |
polymorphisms | 39 |
policy | 39 |
plan | 39 |
measure | 39 |
nursing | 38 |
chance | 38 |
ed | 38 |
establishment | 38 |
eye | 38 |
hygiene | 38 |
intake | 38 |
isolates | 38 |
mobilizers | 38 |
n=1 | 38 |
nurses | 38 |
abdomen | 38 |
output | 38 |
resource | 38 |
participation | 38 |
view | 38 |
saline | 38 |
rst | 38 |
restoration | 38 |
requirements | 38 |
removal | 38 |
questionnaires | 38 |
proportions | 38 |
preservation | 38 |
coli | 37 |
dyspnea | 37 |
defense | 37 |
curves | 37 |
colleagues | 37 |
agonist | 37 |
bronchoscopy | 37 |
boost | 37 |
blockade | 37 |
app | 37 |
anticoagulation | 37 |
guidance | 37 |
enterovirus | 37 |
meeting | 37 |
healing | 37 |
rvis | 37 |
weakness | 37 |
submission | 37 |
intolerance | 37 |
splice | 37 |
stability | 37 |
recruitment | 37 |
posttransplantation | 37 |
odds | 37 |
methylprednisolone | 37 |
member | 37 |
contribution | 36 |
hypoplasia | 36 |
herpesvirus | 36 |
effusion | 36 |
determination | 36 |
decisions | 36 |
cutoff | 36 |
immunosuppressants | 36 |
clone | 36 |
chronic | 36 |
cgy | 36 |
atm | 36 |
array | 36 |
accordance | 36 |
imatinib | 36 |
pancreas | 36 |
inability | 36 |
refractory | 36 |
insulin | 36 |
versushost | 36 |
steps | 36 |
stabilization | 36 |
service | 36 |
satisfaction | 36 |
subject | 36 |
pre | 36 |
outbreaks | 36 |
melphalan | 36 |
medicine | 36 |
macrophage | 36 |
woman | 36 |
codon | 35 |
extremity | 35 |
endoscopy | 35 |
duplication | 35 |
coverage | 35 |
bag | 35 |
chelation | 35 |
blinatumomab | 35 |
atopy | 35 |
antifungal | 35 |
incubation | 35 |
hospitals | 35 |
list | 35 |
light | 35 |
relevance | 35 |
warts | 35 |
likelihood | 35 |
trends | 35 |
third | 35 |
smear | 35 |
veno | 35 |
ranges | 35 |
predisposition | 35 |
neoplasia | 35 |
mold | 35 |
nkg2d | 34 |
agammaglobulinemia | 34 |
aspiration | 34 |
chemokine | 34 |
concept | 34 |
cut | 34 |
doi | 34 |
extremities | 34 |
fumigatus | 34 |
ischemia | 34 |
network | 34 |
contamination | 34 |
organism | 34 |
specifi | 34 |
paper | 34 |
separation | 34 |
probabilities | 34 |
precursors | 34 |
relatives | 34 |
position | 34 |
polymorphism | 34 |
pc | 34 |
paucity | 34 |
discovery | 33 |
hour | 33 |
hair | 33 |
feature | 33 |
etiologies | 33 |
dynamics | 33 |
doxorubicin | 33 |
complaints | 33 |
diet | 33 |
depth | 33 |
correlations | 33 |
consanguinity | 33 |
immunogenicity | 33 |
colonies | 33 |
catheters | 33 |
acids | 33 |
human | 33 |
followup | 33 |
immunophenotype | 33 |
rise | 33 |
immunophenotyping | 33 |
variable | 33 |
upregulation | 33 |
tendency | 33 |
supplementation | 33 |
serotherapy | 33 |
serostatus | 33 |
swelling | 33 |
regulator | 33 |
peptides | 33 |
pandemic | 33 |
pair | 33 |
maximum | 33 |
malnutrition | 33 |
major | 33 |
disparity | 32 |
hypoxia | 32 |
fractions | 32 |
fluids | 32 |
failures | 32 |
error | 32 |
emergence | 32 |
effort | 32 |
dissemination | 32 |
allohsct | 32 |
discrepancies | 32 |
detail | 32 |
c3 | 32 |
behalf | 32 |
autograft | 32 |
art | 32 |
amounts | 32 |
income | 32 |
igm | 32 |
escalation | 32 |
lipid | 32 |
purpura | 32 |
making | 32 |
vaccinations | 32 |
trigger | 32 |
subpopulation | 32 |
shift | 32 |
season | 32 |
ruxolitinib | 32 |
roles | 32 |
thawing | 32 |
power | 32 |
myelofibrosis | 32 |
monotherapy | 32 |
yr | 32 |
modulation | 32 |
minimum | 32 |
masses | 32 |
n=4 | 32 |
charts | 31 |
glucose | 31 |
exchange | 31 |
ex | 31 |
diphtheria | 31 |
delta | 31 |
albicans | 31 |
cessation | 31 |
candida | 31 |
bm | 31 |
acquisition | 31 |
interpretation | 31 |
intensification | 31 |
methylation | 31 |
vessel | 31 |
mode | 31 |
osteopetrosis | 31 |
person | 31 |
restriction | 31 |
route | 31 |
secretions | 31 |
surveys | 31 |
syngeneic | 31 |
vessels | 31 |
α | 31 |
microbiome | 31 |
grant | 30 |
details | 30 |
devices | 30 |
labs | 30 |
homing | 30 |
hormone | 30 |
criterion | 30 |
cytopenia | 30 |
blot | 30 |
conversion | 30 |
comparisons | 30 |
calcineurin | 30 |
burst | 30 |
bridge | 30 |
aid | 30 |
accuracy | 30 |
insight | 30 |
hypothyroidism | 30 |
letermovir | 30 |
prednisolone | 30 |
washing | 30 |
sputum | 30 |
rubella | 30 |
residents | 30 |
rationale | 30 |
predominance | 30 |
th1 | 30 |
percentages | 30 |
manner | 30 |
nurse | 30 |
link | 30 |
leukemias | 30 |
mellitus | 30 |
metabolites | 30 |
neuropathy | 30 |
estimates | 29 |
homeostasis | 29 |
hearing | 29 |
fractures | 29 |
foscarnet | 29 |
experts | 29 |
dehydrogenase | 29 |
enterocolitis | 29 |
ifnγ | 29 |
databases | 29 |
biology | 29 |
attacks | 29 |
anti | 29 |
compliance | 29 |
honoraria | 29 |
influenzae | 29 |
reperfusion | 29 |
matter | 29 |
wound | 29 |
tbf | 29 |
sub | 29 |
scoring | 29 |
subunit | 29 |
rapamycin | 29 |
pbscs | 29 |
myelogenous | 29 |
mod | 29 |
metapneumovirus | 29 |
mcg | 29 |
deposition | 28 |
morphology | 28 |
morbidities | 28 |
manipulation | 28 |
investigators | 28 |
ighy | 28 |
hydroxyurea | 28 |
editing | 28 |
desensitization | 28 |
applications | 28 |
deficits | 28 |
correction | 28 |
cop | 28 |
committee | 28 |
aspirate | 28 |
newborns | 28 |
angiogenesis | 28 |
advantages | 28 |
motor | 28 |
thyroiditis | 28 |
om | 28 |
saml | 28 |
oseltamivir | 28 |
vsts | 28 |
tumours | 28 |
trait | 28 |
staging | 28 |
saturation | 28 |
sampling | 28 |
space | 28 |
recombination | 28 |
pos | 28 |
race | 28 |
people | 28 |
pfts | 28 |
outbreak | 28 |
proteinuria | 28 |
publications | 28 |
curriculum | 27 |
il-2 | 27 |
ii | 27 |
haploinsufficiency | 27 |
functionality | 27 |
formula | 27 |
filter | 27 |
electrophoresis | 27 |
differential | 27 |
1a | 27 |
collagen | 27 |
ataxia | 27 |
arrest | 27 |
anaphylaxis | 27 |
alteration | 27 |
allosct | 27 |
adjustment | 27 |
achievement | 27 |
lead | 27 |
infiltrates | 27 |
institute | 27 |
μg | 27 |
standards | 27 |
≤ | 27 |
lenalidomide | 27 |
volunteers | 27 |
vincristine | 27 |
vancomycin | 27 |
uence | 27 |
strain | 27 |
states | 27 |
thiotepa | 27 |
relationships | 27 |
mrna | 27 |
references | 27 |
lrti | 27 |
microenvironment | 27 |
lineages | 27 |
pancreatitis | 27 |
pathogenicity | 27 |
rearrangements | 27 |
cellulitis | 26 |
enlargement | 26 |
difficulty | 26 |
destruction | 26 |
dataset | 26 |
cross | 26 |
clinician | 26 |
cirrhosis | 26 |
ciprofloxacin | 26 |
exons | 26 |
capture | 26 |
antivirals | 26 |
antibiotic | 26 |
amyloidosis | 26 |
agreement | 26 |
aes | 26 |
abundance | 26 |
+4 | 26 |
examinations | 26 |
testosterone | 26 |
feedback | 26 |
rooms | 26 |
variations | 26 |
filgrastim | 26 |
uptake | 26 |
tongue | 26 |
streptococcus | 26 |
spite | 26 |
skills | 26 |
situations | 26 |
teeth | 26 |
registries | 26 |
peri | 26 |
pcs | 26 |
gf | 26 |
key | 26 |
implantation | 26 |
readmission | 26 |
grants | 26 |
haplotype | 25 |
ethnicity | 25 |
glass | 25 |
goals | 25 |
gradient | 25 |
inheritance | 25 |
infiltrate | 25 |
insertion | 25 |
instrument | 25 |
invasion | 25 |
erythematosus | 25 |
estimation | 25 |
attempts | 25 |
endothelium | 25 |
dl. | 25 |
difficile | 25 |
dcs | 25 |
compatibility | 25 |
circles | 25 |
chapter | 25 |
cellularity | 25 |
anomalies | 25 |
alt | 25 |
aeruginosa | 25 |
leukopenia | 25 |
laboratories | 25 |
sets | 25 |
lymphopenia | 25 |
reductions | 25 |
microangiopathy | 25 |
™ | 25 |
velocities | 25 |
topics | 25 |
thalidomide | 25 |
stream | 25 |
stature | 25 |
spine | 25 |
signals | 25 |
schedules | 25 |
regeneration | 25 |
winter | 25 |
pi | 25 |
oncologists | 25 |
phlebotomy | 25 |
microliter | 25 |
nonsense | 25 |
o0.05 | 25 |
modifications | 25 |
opacities | 25 |
overlap | 25 |
parameter | 25 |
perspective | 25 |
phases | 25 |
genetics | 24 |
dasatinib | 24 |
frameshift | 24 |
frame | 24 |
extension | 24 |
exhaustion | 24 |
exacerbations | 24 |
elements | 24 |
disappearance | 24 |
diarrhoea | 24 |
booster | 24 |
cytometric | 24 |
coefficient | 24 |
cd | 24 |
cars | 24 |
bias | 24 |
bags | 24 |
autoantibody | 24 |
asct | 24 |
animals | 24 |
ground | 24 |
glycoprotein | 24 |
knee | 24 |
incorporation | 24 |
reinfusion | 24 |
worsening | 24 |
insights | 24 |
students | 24 |
structure | 24 |
strength | 24 |
specialists | 24 |
scheme | 24 |
return | 24 |
remainder | 24 |
subclass | 24 |
regime | 24 |
leukocytosis | 24 |
rarity | 24 |
kits | 24 |
leg | 24 |
insurance | 24 |
limitation | 24 |
overexpression | 24 |
p=0.02 | 24 |
pretransplant | 24 |
entities | 23 |
nephritis | 23 |
mab | 23 |
intent | 23 |
indicators | 23 |
hybridization | 23 |
histocompatibility | 23 |
estimate | 23 |
breakthrough | 23 |
core | 23 |
compartments | 23 |
cluster | 23 |
caregiver | 23 |
board | 23 |
author | 23 |
allografting | 23 |
offspring | 23 |
o0.01 | 23 |
wk | 23 |
phenomenon | 23 |
recommendation | 23 |
pool | 23 |
uv | 23 |
text | 23 |
survivorship | 23 |
services | 23 |
seizure | 23 |
reducedintensity | 23 |
synthesis | 23 |
rats | 23 |
pulse | 23 |
profiling | 23 |
preference | 23 |
portion | 23 |
pools | 23 |
quantity | 23 |
erythrocyte | 22 |
codes | 22 |
conjunction | 22 |
cp | 22 |
descent | 22 |
hematocrit | 22 |
explanation | 22 |
facility | 22 |
hepatotoxicity | 22 |
cd8 | 22 |
clots | 22 |
allopurinol | 22 |
cart | 22 |
candidemia | 22 |
bronchitis | 22 |
bleomycin | 22 |
backbone | 22 |
autophagy | 22 |
aspect | 22 |
igg4 | 22 |
allergies | 22 |
+5 | 22 |
ifng | 22 |
elimination | 22 |
islet | 22 |
sorting | 22 |
joints | 22 |
y. | 22 |
warrants | 22 |
veins | 22 |
tree | 22 |
transcripts | 22 |
suspension | 22 |
stromal | 22 |
spread | 22 |
specimen | 22 |
trauma | 22 |
resonance | 22 |
methodology | 22 |
matrix | 22 |
reinduction | 22 |
melanoma | 22 |
mncs | 22 |
multiorgan | 22 |
optimization | 22 |
radiosensitivity | 22 |
registration | 22 |
emesis | 21 |
encounters | 21 |
gold | 21 |
evs | 21 |
exposures | 21 |
feeding | 21 |
foxn1 | 21 |
hypersensitivity | 21 |
hazards | 21 |
histopathology | 21 |
hope | 21 |
immunologists | 21 |
irrigation | 21 |
delays | 21 |
drainage | 21 |
breath | 21 |
degradation | 21 |
definitions | 21 |
ctla-4 | 21 |
covariates | 21 |
contents | 21 |
consumption | 21 |
cdna | 21 |
cc | 21 |
caution | 21 |
cardiomyopathy | 21 |
behavior | 21 |
adulthood | 21 |
activator | 21 |
loads | 21 |
layer | 21 |
discomfort | 21 |
machine | 21 |
sodium | 21 |
multiplex | 21 |
vctl | 21 |
valganciclovir | 21 |
ucbt | 21 |
tonsillectomy | 21 |
throughput | 21 |
terminal | 21 |
sum | 21 |
subclasses | 21 |
streptococci | 21 |
stools | 21 |
ssc | 21 |
spots | 21 |
splicing | 21 |
ward | 21 |
yields | 21 |
platforms | 21 |
osteoporosis | 21 |
parallel | 21 |
pharmacokinetics | 21 |
pharmacy | 21 |
plate | 21 |
plans | 21 |
polysaccharide | 21 |
promoter | 21 |
relative | 21 |
rhinitis | 21 |
scales | 21 |
scenarios | 21 |
separator | 21 |
epitope | 20 |
echocardiogram | 20 |
effusions | 20 |
elevations | 20 |
encoding | 20 |
epistaxis | 20 |
gland | 20 |
erythema | 20 |
exacerbation | 20 |
extraction | 20 |
fibrin | 20 |
foods | 20 |
germ | 20 |
diameter | 20 |
donations | 20 |
chains | 20 |
decontamination | 20 |
cyclosporin | 20 |
considerations | 20 |
confi | 20 |
clinics | 20 |
chromosomes | 20 |
brosis | 20 |
beads | 20 |
b6 | 20 |
axis | 20 |
aspirates | 20 |
appetite | 20 |
algorithms | 20 |
affinity | 20 |
ibrutinib | 20 |
ice | 20 |
ifd | 20 |
session | 20 |
intestine | 20 |
γδ | 20 |
αβ | 20 |
workers | 20 |
volunteer | 20 |
vectors | 20 |
usefulness | 20 |
upfront | 20 |
tcrs | 20 |
survivor | 20 |
sleep | 20 |
sin | 20 |
shingles | 20 |
shedding | 20 |
taper | 20 |
puberty | 20 |
norovirus | 20 |
probe | 20 |
microarray | 20 |
motion | 20 |
neg | 20 |
neuraminidase | 20 |
niche | 20 |
levofloxacin | 20 |
opinion | 20 |
periodontitis | 20 |
precautions | 20 |
precision | 20 |
present | 20 |
partners | 20 |
drop | 19 |
circulation | 19 |
clostridium | 19 |
comfort | 19 |
consultation | 19 |
contacts | 19 |
dialysis | 19 |
fellowship | 19 |
epidermidis | 19 |
erythroid | 19 |
files | 19 |
fungus | 19 |
gastroenteritis | 19 |
chop | 19 |
ciclosporin | 19 |
hemoglobinopathies | 19 |
chills | 19 |
chemokines | 19 |
checkpoint | 19 |
ceftriaxone | 19 |
cation | 19 |
cardiology | 19 |
bmscs | 19 |
block | 19 |
azithromycin | 19 |
atrophy | 19 |
assistance | 19 |
arteries | 19 |
apcs | 19 |
additive | 19 |
aberrations | 19 |
harvesting | 19 |
facilities | 19 |
hpv | 19 |
oxygenation | 19 |
immunologist | 19 |
voxelotor | 19 |
uric | 19 |
stop | 19 |
solutions | 19 |
scid | 19 |
sarcomas | 19 |
rat | 19 |
pulmonary | 19 |
planning | 19 |
phone | 19 |
perforation | 19 |
past | 19 |
pap | 19 |
reporting | 19 |
osteonecrosis | 19 |
mixture | 19 |
occasions | 19 |
indexes | 19 |
individual | 19 |
islets | 19 |
jaundice | 19 |
liquid | 19 |
x10 | 19 |
ml. | 19 |
mycobacteria | 19 |
nerve | 19 |
nfkb1 | 19 |
nose | 19 |
obesity | 19 |
debate | 18 |
engagement | 18 |
degrees | 18 |
dengue | 18 |
dependence | 18 |
discussions | 18 |
ear | 18 |
ejection | 18 |
endocarditis | 18 |
gingivitis | 18 |
enteritis | 18 |
epitopes | 18 |
expressions | 18 |
fold | 18 |
formulation | 18 |
gi | 18 |
hypoxemia | 18 |
d+100 | 18 |
daughter | 18 |
+11 | 18 |
crp | 18 |
angioedema | 18 |
# | 18 |
+ | 18 |
infertility | 18 |
= | 18 |
aims | 18 |
airflow | 18 |
anesthesia | 18 |
anomaly | 18 |
conjugate | 18 |
ayas | 18 |
azathioprine | 18 |
bedside | 18 |
births | 18 |
cardiac | 18 |
cholesterol | 18 |
cmv | 18 |
igg2 | 18 |
framework | 18 |
interleukin | 18 |
reg | 18 |
segments | 18 |
shunt | 18 |
simplex | 18 |
sperm | 18 |
stain | 18 |
stomach | 18 |
tapering | 18 |
termination | 18 |
topic | 18 |
trapping | 18 |
university | 18 |
vgpr | 18 |
wt | 18 |
zone | 18 |
µg | 18 |
intubation | 18 |
δ | 18 |
screens | 18 |
stomatitis | 18 |
rashes | 18 |
p=0.009 | 18 |
items | 18 |
randomization | 18 |
lysate | 18 |
meetings | 18 |
membranes | 18 |
myopathy | 18 |
neurotoxicity | 18 |
organization | 18 |
lactate | 18 |
plateau | 18 |
plcg2 | 18 |
potency | 18 |
promise | 18 |
propranolol | 18 |
pump | 18 |
qpcr | 18 |
enumeration | 17 |
constipation | 17 |
delirium | 17 |
dimer | 17 |
driver | 17 |
ears | 17 |
ease | 17 |
employee | 17 |
encephalitis | 17 |
foci | 17 |
fate | 17 |
fibroblast | 17 |
colonoscopy | 17 |
freezing | 17 |
germline | 17 |
glands | 17 |
grief | 17 |
h. | 17 |
hands | 17 |
conference | 17 |
-10 | 17 |
clusters | 17 |
appointments | 17 |
igd | 17 |
+28 | 17 |
0,01 | 17 |
absorption | 17 |
adenosine | 17 |
ahsct | 17 |
analgesia | 17 |
antimicrobials | 17 |
article | 17 |
cleavage | 17 |
bank | 17 |
bcl11b | 17 |
biallelic | 17 |
bispecific | 17 |
buffering | 17 |
cacy | 17 |
cd20 | 17 |
characteristic | 17 |
hydration | 17 |
thresholds | 17 |
immunizations | 17 |
swab | 17 |
retention | 17 |
reviews | 17 |
seasons | 17 |
sequestration | 17 |
seropositivity | 17 |
sp | 17 |
speech | 17 |
spot | 17 |
teams | 17 |
publication | 17 |
telephone | 17 |
timepoints | 17 |
transcript | 17 |
treosulfan | 17 |
triglycerides | 17 |
trilineage | 17 |
urticaria | 17 |
independence | 17 |
puncture | 17 |
þ | 17 |
proteasome | 17 |
outpatients | 17 |
pretreatment | 17 |
intention | 17 |
learning | 17 |
legs | 17 |
localization | 17 |
methotrexate | 17 |
nm | 17 |
occlusion | 17 |
indices | 17 |
p=0.006 | 17 |
personnel | 17 |
p=0.03 | 17 |
phagocytes | 17 |
perspectives | 17 |
phosphatase | 17 |
peramivir | 17 |
pelvis | 17 |
palivizumab | 17 |
favor | 16 |
disparities | 16 |
disruption | 16 |
emigrants | 16 |
etoposide | 16 |
expert | 16 |
expertise | 16 |
direction | 16 |
histories | 16 |
fitness | 16 |
front | 16 |
hemodialysis | 16 |
immunofluorescence | 16 |
instances | 16 |
integrity | 16 |
investigator | 16 |
leak | 16 |
demand | 16 |
diagnostics | 16 |
cd45ro+ | 16 |
cytokinesis | 16 |
crlf2 | 16 |
mainstay | 16 |
+13 | 16 |
24h | 16 |
adjustments | 16 |
anthracyclines | 16 |
autoinflammation | 16 |
bioavailability | 16 |
bortezomib | 16 |
breathing | 16 |
carvs | 16 |
cd62l | 16 |
circumstances | 16 |
communities | 16 |
computer | 16 |
congestion | 16 |
consultancy | 16 |
costimulation | 16 |
lymphoid | 16 |
code | 16 |
minority | 16 |
serotype | 16 |
stains | 16 |
staphylococci | 16 |
starting | 16 |
statement | 16 |
® | 16 |
stiffness | 16 |
stimuli | 16 |
stock | 16 |
suppressor | 16 |
technologies | 16 |
telangiectasia | 16 |
tetramer | 16 |
thalassaemia | 16 |
today | 16 |
toxoplasma | 16 |
ulcer | 16 |
waiting | 16 |
society | 16 |
multidrug | 16 |
septicemia | 16 |
pretransplantation | 16 |
necessity | 16 |
nephropathy | 16 |
nets | 16 |
nucleoside | 16 |
opportunities | 16 |
plasminogen | 16 |
preparations | 16 |
pericarditis | 16 |
proband | 16 |
relief | 16 |
propensity | 16 |
romiplostim | 16 |
retardation | 16 |
scenario | 16 |
rejections | 16 |
regards | 16 |
section | 16 |
genotyping | 15 |
epidemic | 15 |
expectancy | 15 |
faculty | 15 |
fashion | 15 |
file | 15 |
fluoroquinolone | 15 |
fmt | 15 |
mantle | 15 |
glucocorticoids | 15 |
homology | 15 |
hyperbilirubinaemia | 15 |
ifis | 15 |
iii | 15 |
immunohistochemistry | 15 |
inhalation | 15 |
input | 15 |
embolism | 15 |
emphasis | 15 |
cardiotoxicity | 15 |
dystrophy | 15 |
dp | 15 |
manuscript | 15 |
actions | 15 |
advent | 15 |
agonists | 15 |
airways | 15 |
alloimmunization | 15 |
antigenemia | 15 |
antihistamines | 15 |
bmd | 15 |
brincidofovir | 15 |
continuation | 15 |
cooperation | 15 |
cpx-351 | 15 |
daunorubicin | 15 |
decay | 15 |
der | 15 |
diffuse | 15 |
manufacturer | 15 |
luciferase | 15 |
mds | 15 |
suicide | 15 |
responder | 15 |
rfs | 15 |
rheumatoid | 15 |
rhinoviruses | 15 |
segment | 15 |
shelf | 15 |
sinuses | 15 |
speed | 15 |
surfaces | 15 |
regimes | 15 |
therapeutics | 15 |
transport | 15 |
triad | 15 |
trisomy | 15 |
ulceration | 15 |
users | 15 |
wash | 15 |
methicillin | 15 |
repertoires | 15 |
snps | 15 |
r+ | 15 |
peg | 15 |
modeling | 15 |
purposes | 15 |
morphine | 15 |
nitrogen | 15 |
offunction | 15 |
operation | 15 |
parts | 15 |
pathologies | 15 |
opioids | 15 |
penicillin | 15 |
priming | 15 |
pruritus | 15 |
proof | 15 |
principles | 15 |
provision | 15 |
prescription | 15 |
pharyngitis | 15 |
folate | 14 |
enteropathy | 14 |
energy | 14 |
env | 14 |
eruption | 14 |
es | 14 |
escape | 14 |
existence | 14 |
filtration | 14 |
finger | 14 |
hspcs | 14 |
gestation | 14 |
gliomas | 14 |
haemorrhage | 14 |
hematologists | 14 |
hemophagocytosis | 14 |
heterozygosity | 14 |
hip | 14 |
house | 14 |
ig | 14 |
echocardiograms | 14 |
echocardiography | 14 |
acuity | 14 |
disturbances | 14 |
compounds | 14 |
initiatives | 14 |
+15 | 14 |
ascs | 14 |
batches | 14 |
bodyweight | 14 |
c8 | 14 |
cascade | 14 |
chimeras | 14 |
coinfection | 14 |
contrary | 14 |
discretion | 14 |
copper | 14 |
coronaviruses | 14 |
counterparts | 14 |
cya | 14 |